Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Sacral Neuromodulation System Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Sacral Neuromodulation System Market Status and Forecast (2016-2027)
      • 1.3.2 Global Sacral Neuromodulation System Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Sacral Neuromodulation System Supply by Company

    • 2.1 Global Sacral Neuromodulation System Sales Value by Company
    • 2.2 Sacral Neuromodulation System Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Sacral Neuromodulation System Market Status by Category

    • 3.1 Sacral Neuromodulation System Category Introduction
      • 3.1.1 Internal Neuromodulation System
      • 3.1.2 External Neuromodulation System
    • 3.2 Global Sacral Neuromodulation System Market by Category
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Sacral Neuromodulation System Market Status by End User/Segment

    • 4.1 Sacral Neuromodulation System Segment by End User/Segment
      • 4.1.1 Spinal Cord Stimulation
      • 4.1.2 Deep Brain Stimulation
      • 4.1.3 Sacral Nerve Stimulation
      • 4.1.4 Vagus Nerve Stimulation
    • 4.2 Global Sacral Neuromodulation System Market by End User/Segment
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Sacral Neuromodulation System Market Status by Region

    • 5.1 Global Sacral Neuromodulation System Market by Region
    • 5.2 North America Sacral Neuromodulation System Market Status
    • 5.3 Europe Sacral Neuromodulation System Market Status
    • 5.4 Asia Pacific Sacral Neuromodulation System Market Status
    • 5.5 Central & South America Sacral Neuromodulation System Market Status
    • 5.6 Middle East & Africa Sacral Neuromodulation System Market Status

    6 North America Sacral Neuromodulation System Market Status

    • 6.1 North America Sacral Neuromodulation System Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Sacral Neuromodulation System Market Status

    • 7.1 Europe Sacral Neuromodulation System Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Sacral Neuromodulation System Market Status

    • 8.1 Asia Pacific Sacral Neuromodulation System Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Sacral Neuromodulation System Market Status

    • 9.1 Central & South America Sacral Neuromodulation System Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Sacral Neuromodulation System Market Status

    • 10.1 Middle East & Africa Sacral Neuromodulation System Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Sacral Neuromodulation System Market Forecast by Category and by End User/Segment

    • 12.1 Global Sacral Neuromodulation System Sales Value Forecast (2022-2027)
    • 12.2 Global Sacral Neuromodulation System Forecast by Category
    • 12.3 Global Sacral Neuromodulation System Forecast by End User/Segment

    13 Global Sacral Neuromodulation System Market Forecast by Region/Country

    • 13.1 Global Sacral Neuromodulation System Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Synapse Biomedical, Inc. (US)
      • 14.1.1 Company Information
      • 14.1.2 Sacral Neuromodulation System Product Introduction
      • 14.1.3 Synapse Biomedical, Inc. (US) Sacral Neuromodulation System Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 St. Jude Medical, Inc. (US)
      • 14.2.1 Company Information
      • 14.2.2 Sacral Neuromodulation System Product Introduction
      • 14.2.3 St. Jude Medical, Inc. (US) Sacral Neuromodulation System Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Nevro Corporation (US)
      • 14.3.1 Company Information
      • 14.3.2 Sacral Neuromodulation System Product Introduction
      • 14.3.3 Nevro Corporation (US) Sacral Neuromodulation System Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Neurosigma, Inc. (US)
      • 14.4.1 Company Information
      • 14.4.2 Sacral Neuromodulation System Product Introduction
      • 14.4.3 Neurosigma, Inc. (US) Sacral Neuromodulation System Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Neuropace, Inc. (US)
      • 14.5.1 Company Information
      • 14.5.2 Sacral Neuromodulation System Product Introduction
      • 14.5.3 Neuropace, Inc. (US) Sacral Neuromodulation System Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Neuronetics, Inc. (US)
      • 14.6.1 Company Information
      • 14.6.2 Sacral Neuromodulation System Product Introduction
      • 14.6.3 Neuronetics, Inc. (US) Sacral Neuromodulation System Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Medtronic, Inc. (US)
      • 14.7.1 Company Information
      • 14.7.2 Sacral Neuromodulation System Product Introduction
      • 14.7.3 Medtronic, Inc. (US) Sacral Neuromodulation System Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Cyberonics, Inc. (US)
      • 14.8.1 Company Information
      • 14.8.2 Sacral Neuromodulation System Product Introduction
      • 14.8.3 Cyberonics, Inc. (US) Sacral Neuromodulation System Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Boston Scientific Corporation (US)
      • 14.9.1 Company Information
      • 14.9.2 Sacral Neuromodulation System Product Introduction
      • 14.9.3 Boston Scientific Corporation (US) Sacral Neuromodulation System Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 BioControl Medical (Israel)
      • 14.10.1 Company Information
      • 14.10.2 Sacral Neuromodulation System Product Introduction
      • 14.10.3 BioControl Medical (Israel) Sacral Neuromodulation System Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.10.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Sacral Neuromodulation System market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Sacral Neuromodulation System market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Internal Neuromodulation System
      External Neuromodulation System

      Segmented by End User/Segment
      Spinal Cord Stimulation
      Deep Brain Stimulation
      Sacral Nerve Stimulation
      Vagus Nerve Stimulation

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Synapse Biomedical, Inc. (US)
      St. Jude Medical, Inc. (US)
      Nevro Corporation (US)
      Neurosigma, Inc. (US)
      Neuropace, Inc. (US)
      Neuronetics, Inc. (US)
      Medtronic, Inc. (US)
      Cyberonics, Inc. (US)
      Boston Scientific Corporation (US)
      BioControl Medical (Israel)
      Buy now